Looking ahead to full year 2024, B&G Foods lowered its net sales outlook for a second time to a range of $1.92B to $1.95B from prior guidance of $1.945B to $1.97B. This compares to the consensus ...
Nov 4 (Reuters) - Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments. The drugmaker now expects ...